Global burden associated with rare infectious diseases of poverty in 2021: findings from the Global Burden of Disease Study 2021
There has been a slight reduction in the disease burden of rIDPs over the past three decades. Given that rIDPs mainly affect populations in impoverished regions, targeted health strategies and resource allocation are in great demand for these populations to further control rIDPs and end poverty in all its forms everywhere.
Authors
- Ne Qiang
- Lefei Han (ORCID: https://orcid.org/0000-0003-3254-9527)
- Ka Chun Chong (ORCID: https://orcid.org/0000-0001-5610-1298)
- Yibin Zhou (ORCID: https://orcid.org/0000-0002-5516-9466)
- Shi Zhao (ORCID: https://orcid.org/0000-0001-8722-6149)
- Jinjun Ran (ORCID: https://orcid.org/0000-0002-2684-6341)
- Xiaobei Deng
- Yuzheng Zhang (ORCID: https://orcid.org/0000-0002-4054-6740)
- Yongxuan Li (ORCID: https://orcid.org/0000-0002-7544-252X)
- Xiaoxi Zhang (ORCID: https://orcid.org/0000-0002-7710-9587)
- Tianyun Li (ORCID: https://orcid.org/0000-0002-0557-8907)
- Yujia Bao
Institutions
- Chinese University of Hong Kong (HK)
- Shanghai Jiao Tong University (CN)
- Hong Kong Jockey Club (HK)
- China National Health Development Research Center (CN)
- Shanghai Municipal Center For Disease Control Prevention (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Infectious Diseases of Poverty
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1186/s40249-024-01249-6
- Citations
- 17
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 8.98
Funders
- Bill and Melinda Gates Foundation
- Natural Science Foundation of Shanghai
- Shanghai Science and Technology Development Foundation
- National Natural Science Foundation of China